by European Society of Cardiology Feeling excessively tired, devoid of energy, demoralised, and irritable? You may have burnout, a syndrome associated with a potentially deadly heart rhythm disturbance. That’s the conclusion of a large study published today in the European Journal of Preventive Cardiology, a journal of the European Society of Cardiology (ESC). “Vital exhaustion,...
Post
Telemedicine visits comparable for glycemic control in T1DM
(HealthDay)—Among patients with type 1 diabetes and suboptimal glycemic control, replacement of an intermediate face-to-face visit with a telemedicine session did not affect outcomes, according to a study published online Jan. 6 in Diabetes Care. Maria S. Ruiz de Adana, M.D., Ph.D., from the Hospital Regional Universitario de Málaga in Spain, and colleagues randomly assigned...
Post
Long-term medication for schizophrenia is safe
Researchers at Karolinska Institutet and their colleagues in Germany, the USA and Finland have studied the safety of very long-term antipsychotic therapy for schizophrenia. According to the study, which is published in the scientific journal World Psychiatry, mortality was higher during periods when patients were not on medication than when they were. People with schizophrenia...
Post
Preventing tuberculosis: A big drug price cut paves the way for global scale-up
by Gavin Churchyard, The Conversation Lengthy negotiations ended in good news recently when the price of rifapentine, a lifesaving antibiotic, was marked down by 66% by its manufacturer Sanofi. When combined with another antibiotic (isoniazid), rifapentine can prevent tuberculosis (TB) disease. The move was announced at the Union World Conference on Lung Health in October...
Post
Gout incidence down with SGLT2 inhibitors in type 2 diabetes
Adults with type 2 diabetes newly prescribed a sodium-glucose cotransporter-2 (SGLT2) inhibitor have a lower incidence of gout than those prescribed a glucagon-like peptide-1 (GLP-1) receptor agonist, according to a study published online Jan. 14 in the Annals of Internal Medicine. Michael Fralick, M.D., Ph.D., from Brigham and Women’s Hospital and Harvard Medical School in...
Post
Samsung teams up with startup making vision-assistance headsets
Samsung struck a partnership with IrisVision, a company that makes headsets for users with low vision. Samsung will help the company roll out its technology worldwide. By ELISE REUTER Samsung launched a new partnership with IrisVision, a startup making wearable vision-assistance devices. The Pleasanton, California-based company makes virtual-reality headsets that allow users with low vision...
Post
FDA: Weight-control drug lorcaserin may raise cancer risk
The prescription weight control medicine lorcaserin (Belviq, Belviq XR) may increase the risk for cancer, according to the results of a clinical trial assessing the safety of the drug, the U.S. Food and Drug Administration says. The agency said, “[W]e cannot conclude that lorcaserin contributes to the cancer risk” but “wanted to make the public...
Post
Death rates plunge in older people with diabetes, but not younger people
by Diabetologia New research covering the entire population of Hong Kong shows that while death rates from any cause (all-cause mortality), cardiovascular disease and cancer are plummeting overall and in adults with diabetes aged 45 to 74 years, those in younger adults aged 20 to 44 years are barely changing. Having diabetes as a younger...
Post
Abbott’s Low Dose Neurostimulation for Chronic Pain: CES 2020
MEDGADGET EDITORSEXCLUSIVE, NEUROLOGY, NEUROSURGERY, PAIN MANAGEMENT Abbott is a giant medical technology company, but it kept understated at CES. We had a chance to learn a bit of what the company is doing at the world’s premiere gadget conference, which is the Proclaim XR low dose neuromodulation implant. The Proclaim XR spinal cord stimulator can...
Post
AGEISM CAN SHORTEN LIFE EXPECTANCY
Ageism can harm older people’s health, a review of research in 45 countries across 5 continents shows. The researchers base their analysis on a systematic review of 422 studies around the world that included over 7 million participants. There was evidence of the adverse effects of ageism on older persons in 96% of the studies....